9Yamamoto S,Konishi I,Mamdai M,et al. Cancer . 1997
10Paley P,Staskus KA,Gebhard K,et al. Cancer . 1997
同被引文献13
1Toi M, Matsunmoto T, Bando H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications [ J ].Lancet Oncol,2001,2 ( 11 ) :667 ～ 673.
2Brekken RA, Thorpe PE. Vascular endothelial growth factor and targeting of solid rumors[ J]. Anticancer Res, 2001,21 (6B):4221 ～ 4229.
3Holash J,Maisonpierre PC,Compton D,et al.Vessel cooption,regression,and growth in tumors mediated by angiopoietins and EGF[J].Science,1999,284(5422):1994～1998.
4Fujimoto J,SakaguchiH,AokiI,et al.Clinicanimplications of expression of vascular endothelial growthfactorinmetastaticlesions of ovarian cancers[J].Br J Cancer,2001,85(3):313～316.
5Yamamotos S, Konishi I, Mandai M, et al. Expression of Vascular endothelial growth factor (VEGF) in epithelial ovarian nepolims:Correlation with clinicopathology and patient survvivaal analysis of serum VEGF levels[J]. Br J Cancer,1997,76(9) :1221 ～ 1229.
6Duyndam MC, Hilhorst MC, Schluper HM, et al. Vascular endothelial growth factor165 overexpression stimulates in human ovarian cancer xenografts[ J]. Am J pathol,2002,160:537 ～548.
7Kraft A, Weindel K, Ochs A, et al. Vascular endothelial growth factor in the sera and effusions of patients wtin malignant and non - malignant disease [ J] . Cancer, 1999,85 ( 1 ): 178 ～ 187.
8Oehler MK, Caffier H. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer [ J ]. Anticancer Res,2000,20:5109 ～5112.
